Research Article

Changes in intraocular pressure after ND-yag laser posterior capsulotomy

Hashim Thiab Hassan*

Published: 05/20/2020 | Volume 4 - Issue 1 | Pages: 021-030


Background: The posterior capsule opacification (PCO) is also known as after cataract is a common complication after planned extra capsular cataract extraction (ECCE) with or without intraocular lens (IOL) implantation. The aim of this study was to evaluate the changes in intraocular pressure (IOP) after Nd-Yag laser posterior capsulotomy (LPC) for PCO. The Nd-Yag LPC is a safe and non- invasive procedure and can be performed as an outpatient procedure.

Patients & methods: A total of one hundred eyes with symptomatic intact posterior capsule opacification (PCO) at Glaucoma Department of Alyarmouk Teaching Hospital fulfilling the inclusion criteria were enrolled in the study over a period of 6 months, 64 eyes were aphakic and 36 eyes were pseudophakic, the fellow eye was used as control. The base line pre-laser IOP was measured with the help of Goldmann Applanation Tonometer (GAT) and slit lamp examination before procedure. The pupils were dilated by using 1% tropicamide eye drops. Proparacaine eye drops were used 1-2 times for topical anesthesia, using Nd: YAG laser (VISULAS YAG III Carl Zeiss Meditec AG Germany), an opening of 3-4 mm was made in the posterior lens capsule, ensuring use of least possible energy. IOP was again assessed 1 hours, 24 hour and one week after the procedure.

Results: IOP was checked before laser, at one hour, 24 hour and one week after laser. There was statistically significant (p < 0.001) rise in IOP at one hour in both aphakic and pseudophakic groups from a mean of 12.54 mmHg before laser to a mean of 20.79 mmHg at one hour with an average of 8.35 mmHg from baseline measurement. IOP at one hour rises from 2-5 mmHg in 30 eyes (30%), > 5 mmHg in 46 eyes (46%) and > 10 mmHg in 24 eyes (24%). Every patient had an IOP at one hour equal to or greater than 22 mmHg received anti-glaucoma drugs to control the rise in IOP. At 24 hours IOP decreased to a mean of 13.24 mmHg in both groups. No distinction was made between the aphakic and the pseudophakic groups with regard to IOP changes. In all treated eyes, best corrected visual acuity (VA) was recorded before and at one week after Nd-Yag laser application by Snellen’s chart. After performing a central capsulotomy VA increased in all patients. In no eye was the post-laser VA lower than before laser treatment.

Conclusion: Photo-disruption with Nd-Yag laser is a safe and an effective method in management of PCO. However, there are several complications known to follow capsulotomy as significant rise in IOP and only if we can minimize their frequency or, better still, avoid them altogether, can we accept Nd-Yag LPC as a safe procedure in our effort to restore vision in cases of PCO.

Read Full Article HTML DOI: 10.29328/journal.ijceo.1001029 Cite this Article


  1. Ian J. Constable. Arther Siew Ming Lim. Laser its clinical uses in eye diseases. Second edition. 1990.
  2. Peter S. Hersh. Ophthalmic surgical procedures. First edition. 1988. 381-384.
  3. Kanski JJ. Clinical ophthalmology. A systemic approach. Third edition. 1995.304.305.
  4. Andrew R. Elkington. Helena J. Frank. Clinical optics. 2nd edition. 1991. 18-20.
  5. Daniel Vaughan. Taylor Asbury. Khalid F. Tabbara. General ophthalmology. 12th edition. 1989. 150.412.413.416.417.
  6. Stephen J.H Miller. Parson’s diseases of the eye. 17th edition.1984.179.
  7. Lucas DR. Greer’s ocular pathology. 4th edition. 1989.301.309.
  8. Patrick D. Trevor-Roper. The eye and its disorders. Second edition.1984.449.
  9. Parr J. Introduction to ophthalmology. 3rd edition.1989.193.
  10. Roper MJ. Hall. Stallard’s eye surgery. 7th edition. 1989. 30-31.
  11. Terry AC, Stark WJ, Maumenee AE, Fagadau W. Neodymium-Yag laser for posterior capsulotomy. Am JOphthalmol.1983; 96: 716-720. PubMed:
  12. Kraff MC, Sauders DR, Lieberman HL. Intraocular Pressure and the corneal endothelium after Nd-Yag laser posterior capsulotomy. Relative effect of aphakia and pseudophakia. Arch Ophthalmol. 1985; 103: 511-514. PubMed:
  13. Wizeemann A, Jacobi-KW. Nd-Yag laser capsulotomy in intraocular lenses with reversed optics Klin Monatsbl Augenheilkd. 1984; 184: 175-179 PubMed:
  14. Brown SV, Thomas JV, Belcher CD 3d, Simmons RJ. Effect of pilocarpine in treatment of intraocular pressure elevation following Nd-Yag laser posterior capsulotomy. Ophthalmology. 1985; 98: 354-359. PubMed:
  15. Pham DT, Wollensak J, Beker U. Elevation of intraocular pressure following Nd-Yag laser capsulotomy. Pathogenesis and preventive therapy. Klin Monatsbl Augenheilkd. 1987; 191: 270-274. PubMed:
  16. Boen-Tan TN, Stilma JS. Prevention of IOP-rise following Nd-Yag laser posterior capsulotomy with preoperative timolol eye drops and 1 Tablet acetazolamide 250mg systematically. Doc Ophthalmol. 1986; 64: 59-67. PubMed:
  17. Van der Feltz van der Sloot D, Stilma JS, Boen-Tan TN, Bezemer PD. Prevention of IOP-rise following Nd-Yag laser capsulotomy with topical timolol and indomethacin. Doc Ophthalmol. 1988; 70; 209-214. PubMed:
  18. Loh. RC. NdYag laser, photo-disruption and its clinical applications. Ann Acad Med Singapore. 1989; 18: 186-189. PubMed:
  19. Maltzman BA, Haupt E, Notis C. Relationship between age at time of cataract extraction and time interval before capsulotomy for opacification. Ophthalmic Surg. 1989; 20: 321-324. PubMed:
  20. Zagorski Z, Jaroszynski A, Grunwald W. Use of Nd-Yag laser in cataract extraction. Klin-Oczna. 1990; 92: 184-185.
  21. Barbosa A, Hamard H, Ruellar YM. Effects and complications of Nd-Yag laser posterior capsulotomy after ECCE and posterior chamber implantation. Bull Soc Ophthalmol. 1990; 90: 1576-1578. PubMed:
  22. Albert DW, Wade EC, Parrish RK 2nd, Flynn HW Jr, Slomovic AR, et al. A prospective study of angiographic cystoid macular edema one year after vNd-Yag posterior capsulotomy. Ann Ophthalmol. 1990; 22:139-143. PubMed:
  23. Ladas ID, Pavlopoulos GP, Kokolakis SN, Theodossiadis GP.. Prophylactic use of acetazolamide to prevent IOP elevation following Nd-Yag laser posterior capsulotomy. Br J Ophthalmol.1990; 77: 136-138. PubMed:
  24. Krootila K, Oksala O, von Dickhoff K, Wimalawansa SJ, MacIntyre I, et al. Ocular irritative response to Nd-Yag laser capsulotomy in rabbits: release of calcitonin gene-related peptide and effects of methylsergide. Curr Ege Res.1992; 11: 307-314. PubMed:
  25. Saad M, Dempler U. Risk of dislocation and cataract formation in 240 IO-GEL lenses 4 years experiences. Ophthalmolopy. 1992; 89: 338-341.
  26. Javitt JC, Tielsch JM, Canner JK, Kolb MM, Sommer A, et al. National outcomes of cataract extraction. Increased risk of retinal complication associated with Nd-Yag laser capsulotomy. The cataract patients outcomes research team. Ophthalmology. 1992; 99: 1989-1997. discussing 1497-8. PubMed:
  27. Hunold W, Wirtz M, Kreiner C, Greite JH, Kaden P. Lens epithelium necrosis factor for prevention lens opacity. Fortschr-Ophthalmol.1991; 88: 386-389. PubMed:
  28. O’shea DC, Callen WR, Rhodes WT. Introduction to laser and their application. Optics, Refraction and contact lenses. Ame Academy Ophthalmol. 1994-1995.43.
  29. Aron-Rosa Ds Aron JJ and Cohn HC. Use of pulsed picosecond Nd-Yag laser in 6664 cases. Ame Intra-Ocular implant Soc J. 1984; 0:35-39.
  30. Fram Francus A, Lesperance JR. Ophthalmic laser. 1989; 2: 781.
  31. Holweger RR, Marefat B. Intraocular pressure change after Nd-Yag capsulotomy; J Cataract Refract Surg. 1997; 23: 115-121. PubMed:
  32. Rakofsky S, Koch DD, Faulkner JD, Terry SA, Mandell AI, et al. Levobunolol 0.5% and timolol 0.5% to prevent intraocular pressure elevation after Nd-Yag laser posterior capsulotomy. J Catract Refract Surg. 23: 1075-1080. PubMed:
  33. Ge J, Wand M, Chiang R, Paranhos A, Shields MB. Long-term effect of Nd:YAG laser posterior capsulotomy on intraocular pressure. Arch Ophthalmol. 2000; 118: 1334-1337. PubMed:
  34. Christian Biollotte MD. J Cataract Refract Surg. 2004; 30: 2964-2071.
  35. Unal M, Yücel I, Akar Y. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy. J Cataract Refract Surg. 2006; 32: 1499-1502. PubMed:
  36. Singhal D, Desai R, Desai S, Shastri M, Saxena D. Use of topical brimonidine 0.2% to prevent intraocular pressure elevation following Nd-Yag laser posterior capsulotomy. J Pharmacol Pharmacother. 2011; 2: 104-106. PubMed:
  37. Garg P, Malhotra R, Singh L, Agarwal K, Garg A. Role of prophylactic use of timolol 0.5% in preventing rise of intraocular pressure post Nd-Yag laser posterior capsulotomy: Negrian J Ophthalmol. 2014; 2: 20-23.
  38. Çalli U, Akmaz B, Ayyildiz T, Oral AY, Bulut MN, et al; The Effect of Prophylactic Topical Brimonidine on Intraocular Pressure After Nd: YAG Laser Posterior Capsulotomy: J Kartal TR. 2016; 27: 107-110.
  39. Rao CMS, Satyasrinivas V, Muralikrishna V, Anuhya Y, Barua K. Clinical Study of Visual Outcome and Intraocular Pressure Changes Following Neodymium-doped Yttrium Aluminum Garnet Laser Capsulotomy in Post-operative Cataract Patients with Posterior Capsule Opacification. Int J Scientific Study. 2017; 5: 76-82.
  40. Murtaza B, Hussain AW, Haq AU, Hameed A. Changes in intraocular pressure following high energy Nd-Yag laser posterior capsulotomy; Pak Armed Forces Med J. 2018; 68: 872-875.